During the past decade, Instytut Medycyny Wsi conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut Medycyny Wsi" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instytut Medycyny Wsi" are "Alzheimer's Disease" (1 trials), "Alzheimer´s Disease" (1 trials), "Epilepsy, Partial Seizures" (1 trials), "Epilepsy, Primary Generalized Tonic-Clonic Seizures" (1 trials) and "Generalized Tonic Clonic Seizures" (1 trials). Many other conditions were trialed in "Instytut Medycyny Wsi" in a lesser frequency.

Most popular intervention types in "Instytut Medycyny Wsi" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lanabecestat" (2 trials), "Ozanimod" (1 trials), "Pregabalin" (1 trials) and "Pregabalin Dose Level 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instytut Medycyny Wsi" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Instytut Medycyny Wsi". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instytut Medycyny Wsi, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instytut Medycyny Wsi, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".